baber/WOPTO huggingface dataset:
Patent AU-2019433734-A1 (AU)
Title: Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a complication risk factor
Inventor: UEHARA TAKEKI
IPC: A61P31/16
Filed: 2019-03-12
Abstract: A method for treating an influenza virus infection is described. The disclosed method generally involves administering an effective amount of a compound, for example baloxavir marboxil, to a subject having an influenza virus infection and at least one complication risk factor. Generally, the amount is effective such that a reduction in a time to improvement of at least one symptom of an influenza virus infection is statistically significant as compared to that of a non-treated subject.
Patent WO-2020220094-A1 (WO)
Inventor: SONG NING
IPC: H01R4/24
Filed: 2020-05-01
Abstract: A method of forming a device structure comprising: providing a device component having front and rear surfaces and having at least one electrically conductive region on at least one of the surfaces; providing a contact sheet comprising a polymeric material and at least one electrically conductive element that has a non-circular cross-sectional shape embedded in the polymeric material in a manner such that a surface portion is exposed; applying a bonding material to either one or both of the exposed surface portion and at least one of the electrically conductive regions; positioning the contact sheet relative to the device component such that the bonding material is located between the at least one electrically conductive region and the exposed surface portion; and activating the bonding material such that a bond and an electrically conductive coupling is formed between the at least one electrically conductive region and the exposed surface portion.
Patent WO-2021046594-A1 (WO)
Title: Energy storage system
Inventor: SIEBEL ROHAN MICHAEL
IPC: H02G3/00
Filed: 2020-09-08
Abstract: The invention is directed towards a modular energy storage system for receiving power from a source, storing energy within a storage module, and delivering power to a load. The system includes a master unit containing the storage module for storing energy, and an inverter for receiving AC power and converting to DC power for storage. The system may also include at least one slave unit containing additional storage modules to increase energy storage capacity.
Patent WO-2021097526-A1 (WO)
Inventor: BOULOS SHERIF
IPC: C12N15/113
Filed: 2020-11-19
Abstract: A method comprising the steps of: (a) assessing an expression level of at least one miRNA selected from SEQ ID No's 1-18 in a sample from a subject, and (b) using the expression level to determine an iron status of the subject.
Patent AU-2020201259-A1 (AU)
Title: Data backfilling for continuous glucose monitoring
Inventor: REIHMAN ELI
IPC: G16H15/00
Filed: 2020-02-21
Abstract: Methods and apparatus, including computer program products, are provided for backfilling. In some example embodiments, there is provided a method that includes receiving, at a receiver, backfill data representative of sensor data stored, at a continuous blood glucose sensor and transmitter assembly, due to a loss of a wireless link between the receiver and the continuous blood glucose sensor and transmitter assembly; generating, at the receiver, at least one of a notification or a graphically distinct indicator for presentation at a display of the receiver, the at least one of the notification or the graphically distinct indicator enabling the backfill data to be graphically distinguished, when presented at the display, from non-backfill data; and generating, at the receiver, a view including the backfill data, the non-backfill data, and the generated at least one of the notification or the graphically distinct indicator. Related systems, methods, and articles of manufacture are also described. - -- -- - -. -- ---- /) z
Patent AU-2020202546-A1 (AU)
Title: Stackable container with anti-sticking rim
Inventor: MO HELAN
IPC: B65D77/20
Filed: 2020-04-15
Abstract: (Figure 1) 
A container rim 10, in this case for a stackable rectangular container 11, the body of the 
container not being part of the invention is shown in phantom at 12. The rim 10 has an inner 
peripheral edge 13 which is continuous and uninterrupted. This edge 13 is the upper edge of 
the body 12. The rim 10 has an outward top flange 14 which is a continuous surface with the 
edge 13 and is completely uninterrupted along its inner edge 13 and provides a marginal weld 
surface for a closure film extending out to a return flange 15. The return flange 15 has spaced 
denesting stand off projections 16-27. Each projection 16-27 is an outward deformation of the 
top flange 14 and the return flange 15 and they are unevenly spaced so that if an identical 
container is rotated 1800 into a stack a non-deformed or straight section of the edge 28 of flange 
15 will be in line with a projection of the previous container. Thus containers are blocked from 
sticking together. The uninterrupted inner edge 13 ensures the integrity of a peelable sealing 
film 29 notwithstanding the use of the projections 16-27. The projections are in the top flange 
and the return flange so they are as high as possible thus maximising packing density.
C1/8 
0 (9 
LL 
ILDI
Patent AU-2020202702-A1 (AU)
Title: Semi-synthetic powder material, obtained by modifying the composition of a natural marine biomaterial, method for producing same, and applications thereof
Inventor: CAMPRASSE GEORGES
IPC: A61L24/00
Filed: 2020-04-22
Abstract: The invention relates to a pulverulent semisynthetic material, derived from a natural marine biomaterial, namely the aragonitic inner layer of the shell of bivalve molluscs selected from the group comprising Pinctadines, notably Pinctada maxima, margaritifera, and Tridacnes, notably Tridacna gigas, maxima, derasa, tevaroa, squamosa, crocea, Hippopus hippopus, Hippopus porcelanus, in pulverulent form, with addition of insoluble and soluble biopolymers and calcium carbonate transformed by carbonation; it also relates to the method of preparation thereof and to the uses thereof.
Patent AU-2020203171-A1 (AU)
Title: Method, apparatus and system for user interactive IoT verification based on radio frequency tag
Inventor: ZHANG HUI
IPC: G06K19/07
Filed: 2020-04-23
Abstract: An objective of the present application is to provide a method, apparatus and system 
for user interactive IoT verification based on a radio frequency tag. Compared with the prior 
art, in the present application, through interaction with a user who ordered a commodity, a 
user password set by the user or determined by a network device and sent to the user is 
acquired, and the user password and chip feature information of a radio frequency tag are 
verified together, so that the user password is introduced into anti-counterfeiting verification 
of the radio frequency tag through the interaction with the user. Since the user can actively 
participate in the anti-counterfeiting of the commodity, a platform party is prevented from 
unilaterally manipulating an anti-counterfeiting system. The use of an IoT method and a 
server verification technology ensures that a chip can uniquely refer to a specific commodity, 
thereby avoiding replacement and/or reuse. Even if the user password is leaked, a third party 
overwrites the same content with a chip of the same format, or a chip tag is replaced and 
reused, the present solution can directly detect all of the above situations, and form a complete 
and effective commodity anti-counterfeiting system that can be used commercially.
1/7 
15 15 11 
12 14 
Fig. I
Patent AU-2020215849-A1 (AU)
Title: The use of an mGluR5 antagonist for treating opioid analgesic tolerance
Inventor: DOLMETSCH RICHARD CARL ELCIARIO
IPC: A61K31/215
Filed: 2020-01-28
Abstract: The invention relates to the use of a mGluR5 antagonist for the treatment of opioid analgesic tolerance associated with chronic opioid use in chronic pain.
Patent AU-2020219097-A1 (AU)
Title: Genetically modified hematopoietic stem and progenitor cells (HSPCs) and mesenchymal cells as a platform to reduce or prevent metastasis, treat autoimmune and inflammatory disorders, and rebalance the immune milieu and dysregulated niches
Inventor: KAPLAN ROSANDRA N
IPC: C12N5/0775
Filed: 2020-02-10
Abstract: Provided are compositions comprising genetically modified hematopoietic stem and progenitor cells (HSPCs) and/or genetically modified mesenchymal cells, wherein the cells contain a vector comprising a transgene, as well as methods of producing the genetically modified HSPCs and genetically modified mesenchymal cells, and methods of treating or preventing cancer (e.g., metastasis) and neurodegenerative conditions, autoimmune disorders, and inflammatory disorders.
Patent AU-2020270071-A1 (AU)
Title: Non-HLA markers of transplant rejection
Inventor: REED ELAINE F
IPC: A61K39/00
Filed: 2020-05-06
Abstract: The present invention generally relates to transplantation rejection. In particular, the present invention provides compositions, kits, assays, and methods of determining if a subject has allograft rejection, or an increased risk of developing rejection after transplantation, and methods of treatment thereof.
Patent AU-2020321099-A1 (AU)
Title: Method of inspecting and monitoring a fiber termination
Inventor: CAMPBELL RICHARD V
IPC: F16L3/00
Filed: 2020-01-27
Abstract: A system for monitoring the performance of a multi-stranded tensile member where a portion of the strands are concealed within a termination. The invention provides a monitoring system that allows the user to determine when one or more of the strands has degraded to a point of concern. In some embodiments the monitoring system depends on visual inspection and in other embodiments the monitoring system is automated.
Patent AU-2020339086-A1 (AU)
Title: B-cell maturation complex CAR T construct and primers
Inventor: GEORGE REBECCA
IPC: A61K39/00
Filed: 2020-08-28
Abstract: The present invention provides probe and primer sets, and related methods and kits, for generating B-cell maturation antigen chimeric antigen receptor (CAR) T cells. The invention also provides probe and primer sets, and related methods and kits, for performing quantitative polymerase chain reactions to quantitate B-cell maturation antigen CAR transgene integration into a CAR T drug product.
Patent AU-2020342995-A1 (AU)
Title: Armored data cable assembly
Inventor: KRAWCZYK ROMAN
IPC: G02B6/44
Filed: 2020-09-04
Abstract: A data cable assembly includes at least one pair of conductors twisted about one another, optionally disposed along an outer surface of a pair separator. The conductors are covered by an inner jacket, and an armor disposed on the outer surface of the inner jacket. The inner jacket is covered by an outer jacket with a rip cord disposed between the armor and the outer jacket
Patent AU-2020351634-A1 (AU)
Title: Cutting method of workpiece for obtaining a high integrity surface
Inventor: LI ANHAI
IPC: B23B1/00
Filed: 2020-06-12
Abstract: Disclosed is a method for machining a workpiece by means of cutting same to obtain a surface with high integrity. In the method, after rough cutting, a workpiece is subjected to at least one instance of forward fine cutting and at least one instance of reverse fine cutting. Each instance of forward fine cutting and reverse fine cutting is carried out in multiple steps, and in two adjacent steps, the cut machined surface that has been subjected to the cutting of the previous step is subjected to the cutting of the later step. The specific steps of the forward fine cutting comprise: feeding a cutting tool forward from a forward feeding starting point, cutting the surface of the workpiece within the range of a first set distance to complete a first step of forward cutting for the workpiece, the workpiece returning to the starting point, feeding the workpiece forward again, and cutting the surface of the workpiece within a range twice the first set distance to complete a second step of forward cutting for the workpiece. The method for machining a workpiece by means of cutting same to obtain a surface with high integrity can reduce the residual tensile stress and the surface roughness of the surface of the workpiece and stabilize the hardness within a rational range.
Patent AU-2020358853-A1 (AU)
Title: Stacking artificial lash extensions
Inventor: LOTTI SAHARA
IPC: A41G5/02
Filed: 2020-10-02
Abstract: An artificial lash extension system (200, 300) includes lash extensions designed for an application under a natural lash (102A). First lash extensions (200) designed for an application at an underside of a natural lash each include first artificial hairs and a first base from which the first artificial hairs protrude, wherein the first base includes a top side designed to attach to the underside of the natural lash. Second lash extensions (300) designed for an application under the first plurality of lashes each include second artificial hairs, and a second base from which the second artificial hairs protrude, wherein the second base includes a top side designed to attach to at least part of a bottom side of one or more of the first lash extensions.
Patent AU-2020369009-A1 (AU)
Title: A flow control device for a refrigerated display case and a refrigerated display case
Inventor: WIRTH NICHOLAS
IPC: F21V7/00
Filed: 2020-09-30
Abstract: A flow control device for controlling an air curtain formed across a display area of a refrigerated display case, the flow control device comprising: a stabilising beam comprising an elongate outer cover (52) and a carrier (54); wherein the outer cover (52) forms a continuous boundary which defines a cavity (56) extending along the length of the outer cover (52); wherein the carrier (54) is slidably received within the cavity (56) along the length of the outer cover (52); wherein the carrier (54) is provided with a light source (68) and wherein at least a portion of the outer cover (52) is transparent or translucent such that light emitted by the light source is emitted from the outer cover (52) to provide illumination.
Patent AU-2020377991-A1 (AU)
Title: Functionally modified maytansinoids and compositions and methods of use thereof
Inventor: XIE JIN
IPC: C07D405/00
Filed: 2020-11-05
Abstract: Radiosensitizer prodrugs and formulations and methods of use thereof are provided. Typically, the radiosensitizer prodrug is an analog of a radiosensitizer parent compound having one or more S-nitrosothiol moieties. Typically, the S-N bond of the S-nitrosothiol moiety can be cleaved by radiation during radiotherapy, releasing the parent compound and nitric oxide. One or preferably both the parent compound and the nitric oxide can contribute to death of tumor cells exposed to radiotherapy. Nanoparticle formulations for delivery of the prodrug, and methods of using them in combination with radiotherapy to treat tumors and cancer are also provided.
Patent AU-2020393167-A1 (AU)
Title: Device and method for detecting reactive luminescent nano- or micro- particles
Inventor: PEREIRA AREDE JOÃO PAULO
IPC: G01N21/64
Filed: 2020-11-25
Abstract: Device for detecting reactive luminescent particles embedded in a substrate or surface comprising: an infrared or ultraviolet illuminator (101) for illuminating the luminescent particles; a near-infrared photodiode sensor (102) for capturing a near-infrared response of the illuminated luminescent particles; a dark chamber for placing over the substrate or surface, inside which the illuminator (101) and photodiode sensor (102) are mounted; a logarithm amplifier for amplifying and linearizing a response signal captured by the photodiode sensor (102); an electronic data processor configured for detecting the reactive luminescent particles, by carrying out the steps of: illuminating the substrate or surface with the illuminator; acquiring the amplified linearized signal captured by the photodiode sensor; detecting the presence of luminescent particles in the substrate or surface from the linearized decay of the acquired signal. It comprises a further near-infrared photodiode sensor (501), a further logarithm amplifier, and a differentiator for obtaining a difference between amplified signals received by each photodiode sensor (501).
Patent AU-2020396358-A1 (AU)
Title: A method and apparatus for respiratory secretion collection and analysis
Inventor: ROSTOM SHAIKH SALAH EL DIN
IPC: G01N33/569
Filed: 2020-12-04
Abstract: The invention relates to a respiratory secretion sample collection device that includes a collection reservoir for directly receiving a sample of a respiratory secretion, a displacement member for insertion into the collection reservoir and displacing the sample within the collection reservoir, a container of a diluent for fluid communication with the sample for mixing the diluent with the sample, and an outlet for discharging the mixture of the diluent and the sample to an assay device. In embodiments, the precise volumes of the sample and the diluent are effectively mixed to enable the conduct of assays for which the relative concentration of diluent and sample is critical.
Patent AU-2021202095-A1 (AU)
Title: Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
Inventor: SMITH ERNEST S
IPC: A61K38/00
Filed: 2021-04-06
Abstract: Provided are methods for alleviating symptoms in a subject having a neurodegenerative 
disorder, comprising administering to the subject an effective amount of an isolated binding 
molecule which specifically binds to semaphorin-4D (SEMA4D) or to its Plexin-B1 or Plexin
B2 receptors. Further provided is an isolated binding molecule which specifically binds to the 
same SEMA4D epitope as a reference monoclonal antibody selected from the group consisting 
of VXl 5/2503 and 67.
Patent AU-2021221661-A1 (AU)
Title: A sensor-enabled platform configured to measure athletic activity
Inventor: GRAHAM MAT
IPC: A63B65/06
Filed: 2021-08-25
Abstract: The present invention relates, in various embodiment's, to a sensor-enabled platform configured to 
measure athletic activity. For example, some embodiment's provide a platform which is configured to 
enable medicine ball workouts, with the sensors being configured to measure participant performance in 
performing medicine ball exercises. Although the present invention is described primarily in connection 
with such examples, it will be appreciated that further embodiment's find wider application.
5/6 
8 
31 
-32 
Sensor Inputs Display/Controller Interface 
33 
34 
Microprocessor Communications Interfaces 
(Wired/Wireless) 
35 
36 
User Interfame Module Sensor Data Processing 
Module 
38 
Training Program Logic User Customisation Module 
Module 
40 
Storage Module System Link 
Coordination 
Module 
Processing System 
FIG. 5
Patent AU-2021234115-A1 (AU)
Title: A centrifugal separator
Inventor: ELIASSON THOMAS
IPC: F16C27/08
Filed: 2021-03-11
Abstract: A centrifugal separator is configured for processing a product by separating a relatively heavy component and a relatively light component therefrom. The centrifugal separator comprises a spindle (3) supported by a stationary frame (2). A drive unit (4) acts on a rotating member (5) mounted on the spindle to rotate the spindle. A centrifuge rotor (8) mounted to the spindle encloses a separation space (9). An upper bearing housing (20) is mounted to the stationary frame and supports bearings (22, 23) comprising an outer bearing ring (24) attached to the upper bearing housing and an inner bearing ring (25) attached to the spindle. The upper bearing housing is mounted to the stationary frame (2) via an elastic member (40) permitting the upper bearing housing and the spindle to move radially, and via an upper tilting member (41) permitting the spindle to tilt during operation of the centrifugal separator.
Patent AU-2021248598-A1 (AU)
Title: Method for electrochemical hydrogen separation from natural-gas pipelines
Inventor: HENSCHEL CARSTEN
IPC: B01D53/22
Filed: 2021-03-26
Abstract: The present invention relates to a one-stage membrane method for the electrochemical separation of hydrogen from natural-gas flows in a pipeline (1) that has a positive pressure in the range of 50 mbar to 100 bar, the method having the following method steps: (i) a partial gas flow (2) is drawn from the natural-gas flow in a pipeline (1) without altering the gas composition, the mass flow of the partial gas flow being set depending on the hydrogen content in the natural-gas flow (1) such that, with a hydrogen concentration of <10 vol. %, a degree of depletion of 0.65 to 0.975 is achieved, and, with a hydrogen concentration of >10 vol. %, a degree of depletion of 0.55 to 0.925 is achieved, the degree of depletion being defined as the quotient of the desired molar H2 product flow (6) and of the molar H2 reactant volume flow of the partial gas flow at the inlet of the membrane unit (2); (ii) this partial gas flow (2) is compressed (3) upstream of a membrane unit (5); (iii) this partial gas flow is heated to 100 to 250°C, either upstream of the membrane unit or in the membrane unit, and water (4) is supplied to this partial gas flow upstream of the membrane unit and/or on the permeate side of the membrane unit (4a) so that the water load is between 0.005 to 0.2 mol water/mol natural gas; (iv) this partial gas flow is supplied to an electrochemical membrane unit in which hydrogen is separated as permeate (6a) at a temperature of 100 to 250°C; (v) the retentate (8) of the membrane unit is supplied back into the natural-gas flow, is supplied for use in a chemical process, and/or is used as fuel. The present invention also relates to a method for determining the optimised partial gas flow that is drawn from a pipeline conveying natural gas and hydrogen, in order to separate hydrogen from this partial gas flow in an electrochemical membrane unit.
Patent AU-2021271961-A1 (AU)
Title: Oncolytic virus vaccine and drug for treating tumors by combining oncolytic virus vaccine with immune cells
Inventor: ZHOU GUOQING
IPC: C12N7/04
Filed: 2021-05-11
Abstract: Provided are an oncolytic virus attenuated strain, an oncolytic virus vaccine and a drug for treating tumors by combining the oncolytic virus vaccine with immune cells. Provided is a new oncolytic virus attenuated strain, which is obtained by means of the site-directed mutation of a VSV wild-type virus matrix protein M. Also provided is a vaccine capable of being applied to tumor treatment on the basis of the oncolytic virus attenuated strain. Further provided is a drug capable of efficiently treating various tumors by means of applying the vaccine and immune cells in combination on the basis of the vaccine.
Patent AU-2021277601-A1 (AU)
Title: Factor VIII polypeptide formulations
Inventor: MALONEY KEVIN
IPC: A61K38/37
Filed: 2021-11-29
Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and 
methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a 
short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation 
comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, 
episodic (on-demand) treatment, or perioperative management of hemophilia.
Patent AU-2021291231-A1 (AU)
Title: Self-amplifying SARS-CoV-2 RNA vaccine
Inventor: SAHU ITISHRI
IPC: A61P31/14
Filed: 2021-06-18
Abstract: The present invention relates self-replicating RNA molecules comprising a sequence encoding nonstructural alphavirus proteins and a sequence encoding a SARS-CoV-5 2 protein antigen.
Patent AU-2021296826-A1 (AU)
Title: Systems, methods, and apparatus for ocular laser therapy
Inventor: HEREKAR ANJALI
IPC: A61F7/00
Filed: 2021-06-23
Abstract: Near-infrared/Mid-infrared lasers are used to de-claudicate glaucomatous tissue, translocate extra-ocular muscles, thermally pulsate palpebrae, and permeate/vasodilate superficial/epi-scleral membranes for drug delivery. Diffractive optic element-mediated laser patterns may irradiate eye tissues under pulsed or continuous wave regimes with programmable durations and sequences for efficient treatments while minimizing adverse effects.